Mohamed Hussein, Durayd Alzoubaidi, Alvaro de la Serna, Michael Weaver, Jacobo O Fernandez-Sordo, Johannes W Rey, Bu'Hussain Hayee, Edward Despott, Alberto Murino, Sulleman Moreea, Phil Boger, Jason Dunn, Inder Mainie, David Graham, Dan Mullady, Dayna Early, Krish Ragunath, John Anderson, Pradeep Bhandari, Martin Goetz, Ralf Kiesslich, Emmanuel Coron, Enrique R de Santiago, Tamas Gonda, Laurence B Lovat, Rehan Haidry
INTRODUCTION: With increasing advances in minimally invasive endoscopic therapies and endoscopic resection techniques for luminal disease, there is an increased risk of post-procedure bleeding. This can contribute to significant burden on patient's quality of life and health resources when reintervention is required. Hemospray (Cook Medical, North Carolina, USA) is a novel haemostatic powder licensed for gastrointestinal bleeding. The aim of this single-arm, prospective, non-randomised multicentre international study is to look at outcomes in patients with upper gastrointestinal bleeds following elective endoscopic therapy treated with Hemospray to achieve haemostasis...
June 26, 2020: United European Gastroenterology Journal